apitope.com

Apitope | Developing new therapies for the treatment of autoimmune and allergic diseases

Developing new therapies for the treatment of autoimmune and allergic diseases. Leadership & Senior Management Team. Auto-immune Diseases & Allergies. Elimination of Anti-drug Antibodies. Apitope is a European biotech company focused on the discovery and development of revolutionary disease modifying therapies for autoimmune and allergic diseases, including multiple sclerosis, Graves’ disease, FVIII intolerance and uveitis. Apitope Receives Orphan Designation in the European Union for ATX-F8-117 for the ...

http://www.apitope.com/

OVERVIEW OF apitope.com

TRAFFIC RANK

>1,000,000

REVIEWS

0

PAGES IN THIS WEBSITE

20

LINKS TO THIS WEBSITE

CONTACTS

ADDRESSES

SOCIAL LINKS

ONLINE SINCE

WEBSITE DETAILS

SEO

PAGES

SIMILAR SITES

TRAFFIC RANK FOR APITOPE.COM

TODAY'S RATING

>1,000,000

TRAFFIC RANK - AVERAGE PER MONTH

BEST MONTH

March

AVERAGE PER DAY Of THE WEEK

HIGHEST TRAFFIC ON

Thursday

TRAFFIC BY CITY

Sign up

CUSTOMER REVIEWS

Average Rating: 3.6 out of 5 with 9 reviews

5 star

3

4 star

1

3 star

4

2 star

0

1 star

1

Hey there! Start your review of apitope.com

AVERAGE USER RATING

Write a Review

WEBSITE PREVIEW

LOAD TIME

7.5 seconds

CONTACTS AT APITOPE.COM

APITOPE TECHNOLOGY (BRISTOL) LTD

Univers●●●●●●●te East

Ar●●ow , BS1 5UB

GB

View this contact

Namesco Limited

Domain Administrator

Acton Hou●●●●●●●●●well Park

Wor●●●ter , WR3 7GD

GB

44 84●●●●●33630

tr●●●●●●●●●●●●@names.co.uk

View this contact

Namesco Limited

Namesco Limited

Acton Hou●●●●●●●●●well Park

Wor●●●ter , WR3 7GD

GB

44 84●●●●●33630

44 84●●●●● 3631

re●●●●●●●●●@names.co.uk

View this contact

ADD CONTACT

Login

TO VIEW CONTACTS

Remove Contacts

FOR PRIVACY ISSUES

DOMAIN REGISTRATION INFORMATION

REGISTERED: 2005 December 16
UPDATED: 2013 November 18
EXPIRATION: EXPIRED REGISTER THIS DOMAIN

BUY YOUR DOMAIN

DOMAIN AGE

19

YEARS
4

MONTHS
13

DAYS

NAME SERVERS

1: ns0.phase8.net
2: ns1.phase8.net
3: ns2.phase8.net

REGISTRAR

REGISTER.IT SPA

WHOIS : whois.register.it

REFERRED : http://we.register.it

CONTENT

PAGES IN
THIS WEBSITE

20

SSL

EXTERNAL LINKS

10

SITE IP

46.32.225.146

LOAD TIME

7.461 sec

SCORE

6.2

PAGE TITLE

Apitope | Developing new therapies for the treatment of autoimmune and allergic diseases | apitope.com Reviews

<META> DESCRIPTION

Developing new therapies for the treatment of autoimmune and allergic diseases. Leadership & Senior Management Team. Auto-immune Diseases & Allergies. Elimination of Anti-drug Antibodies. Apitope is a European biotech company focused on the discovery and development of revolutionary disease modifying therapies for autoimmune and allergic diseases, including multiple sclerosis, Graves’ disease, FVIII intolerance and uveitis. Apitope Receives Orphan Designation in the European Union for ATX-F8-117 for the ...

<META> KEYWORDS

1 apitope

2 about apitope

3 board of directors

4 scientific advisory board

5 investors

6 technology

7 apitope characteristics

8 discovery process

9 potential applications

10 pipeline

CONTENT

Page content here

KEYWORDS ON PAGE

apitope,about apitope,board of directors,scientific advisory board,investors,technology,apitope characteristics,discovery process,potential applications,pipeline,multiple sclerosis,graves’ disease,factor viii intolerance,uveitis,news,event schedule,menu

SERVER

Apache/2.2.27 (Unix) mod_ssl/2.2.27 OpenSSL/1.0.1e-fips mod_bwlimited/1.4

POWERED BY

PHP/5.4.28

CONTENT-TYPE

utf-8

GOOGLE PREVIEW

Apitope | Developing new therapies for the treatment of autoimmune and allergic diseases | apitope.com Reviews

https://apitope.com

Developing new therapies for the treatment of autoimmune and allergic diseases. Leadership & Senior Management Team. Auto-immune Diseases & Allergies. Elimination of Anti-drug Antibodies. Apitope is a European biotech company focused on the discovery and development of revolutionary disease modifying therapies for autoimmune and allergic diseases, including multiple sclerosis, Graves’ disease, FVIII intolerance and uveitis. Apitope Receives Orphan Designation in the European Union for ATX-F8-117 for the ...

INTERNAL PAGES

apitope.com

1

Apitope | Multiple Sclerosis - Apitope

http://apitope.com/multiple-sclerosis

Developing new therapies for the treatment of autoimmune and allergic diseases. Leadership & Senior Management Team. Auto-immune Diseases & Allergies. Elimination of Anti-drug Antibodies. Multiple sclerosis (MS) is a chronic, inflammatory condition of the nervous system and is the most common, non-traumatic, disabling neurological disease in young adults, with most sufferers developing the disease between the ages of 20 and 40. ATX-MS-1467 is a novel peptide-based therapeutic derived from Apitope’s propr...

2

Apitope | Partnering - Apitope

http://apitope.com/partnering

Developing new therapies for the treatment of autoimmune and allergic diseases. Leadership & Senior Management Team. Auto-immune Diseases & Allergies. Elimination of Anti-drug Antibodies. To further strengthen its position, Apitope is seeking to partner with pharmaceutical or biotechnology companies for the further development and marketing of its pipeline. Apitope is also interested in acquiring the rights to complementary novel product candidates to treat autoimmune diseases. May 9, 2016. March 9, 2016.

3

Apitope | Uveitis - Apitope

http://apitope.com/uveitis

Developing new therapies for the treatment of autoimmune and allergic diseases. Leadership & Senior Management Team. Auto-immune Diseases & Allergies. Elimination of Anti-drug Antibodies. It has been shown that regulatory T cell (T. Numbers are decreased in patients with active uveitis but return to normal in those patients that achieve remission. This is in line with the conclusion that successful therapy is associated with a restoration of T. Web design by Nialto Services.

4

Apitope | Events - Apitope

http://apitope.com/events

Developing new therapies for the treatment of autoimmune and allergic diseases. Leadership & Senior Management Team. Auto-immune Diseases & Allergies. Elimination of Anti-drug Antibodies. Apitope to Present at Bio quity Europe in May 2016. May 9, 2016. Apitope wins prize for presentation at the European Association for Haemophilia and Associated Disorders. March 9, 2016. Apitope Raises 12 Million in Series B Funding to Progress Treatments for Autoimmune Diseases. September 29, 2015. August 6, 2015.

5

Apitope | Background to Auto-immunity - Apitope

http://apitope.com/background-auto-immunity

Developing new therapies for the treatment of autoimmune and allergic diseases. Leadership & Senior Management Team. Auto-immune Diseases & Allergies. Elimination of Anti-drug Antibodies. Autoimmune Diseases and Allergies. Treatment and the patient’s quality of life would greatly improve by targeting the fundamental cause of the disease rather than non-specific immune suppression and symptom treatment. The ultimate aim for treatment is to re-instate self-tolerance to an otherwise innocuous self-antig...

UPGRADE TO PREMIUM TO VIEW 15 MORE

TOTAL PAGES IN THIS WEBSITE

20

LINKS TO THIS WEBSITE

esclerosemultipla.wordpress.com

CHECK-UP | TODOS OS POSTS | Esclerose Múltipla | tudo sobre esclerose múltipla: informações, curiosidades e assuntos relevantes

https://esclerosemultipla.wordpress.com/snc/home/check-up-completo

SNC – Somos Naturalmente Curiosos. RNM – Roteiro de Navegação Médica. LCR – Leis e Conteúdo Relacionado. Esclerose múltipla não permite contratação em vaga para deficiente. Posted by Esclerose Múltipla in Legislação e afins. De acordo com a decisão da 12ª Vara do Trabalho de Brasília, a condição apresentada pela autora da ação não se enquadra em nenhuma das três modalidades de deficiência previstas no. Decreto 3.298, de 1999. Auditiva, visual e mental. Antes dos 18 anos. Dessa maneira, diante das disposi...

daviad.eu

DAVIAD Project | Daviad Project Partners - DAVIAD Project

http://www.daviad.eu/partners

Terms & Conditions. Development of a novel therapeutic vaccine for Graves' disease. Apitope is a privately owned European biotech company developing antigen specific therapeutic peptides for the treatment of allergy and autoimmune diseases, including multiple sclerosis, Graves’ disease, Uveitis, and others. Development of a novel therapeutic vaccine for Graves' disease.

lachesisfund.co.uk

IAC Member Profiles

http://lachesisfund.co.uk/iac-member-profiles.html

Mr Pete Le Noury. Dr Martin is currently the Chief Executive Officer of Apitope Technology (Bristol) Ltd. A biopharmaceutical company developing therapeutic peptides for the treatment of allergy and autoimmune diseases. He is also a non-executive director of Beckpharma Ltd., a specialty biopharmaceutical company.

bris.ac.uk

September: Scientists discover how to ‘switch off’ autoimmune diseases | News | University of Bristol

http://www.bris.ac.uk/news/2014/september/autoimmune-disease.html

Scientists discover how to ‘switch off’ autoimmune diseases. Aggressor cells, which have the potential to cause autoimmunity, are targeted by treatment, causing conversion of these cells to protector cells. Gene expression changes gradually at each stage of treatment, as illustrated by the colour changes in this series of heat maps. Dr Bronwen Burton. The study, funded by the Wellcome Trust. Is published today [03 September] in. This type of conversion has been previously applied to allergies, known as &...

wyvernfund.com

Wyvernfund.com - Portfolio

http://www.wyvernfund.com/portfolio.html

The Wyvern Seed Fund has a mixed portfolio of investments across the two Universities. In addition to investments into new spin-out companies the Fund has been used to support the development and commercialisation of academic research and Intellectual Property, for example by establishing License Agreements or other collaborative ways of returning value from the science/technology. Apitope Technology is a biopharmaceutical company developing treatments for allergy and autoimmune diseases. Perpetuum has d...

UPGRADE TO PREMIUM TO VIEW 5 MORE

TOTAL LINKS TO THIS WEBSITE

10

OTHER SITES

apitools.com

APItools

API Zen for App Developers and DevOps. The traffic between your app and the APIs you use. Stay in complete control. Troubleshoot, Modify, Monitor API traffic. Modify API traffic to get a different output. Check our middleware on GitHub. See what APItools can do for you! Making developers lives easier since 2014. We believe allowing the community to contribute is essential for a top-notch product, so we open-sourced APItools under the MIT license. Check out the code on Github. Setting up APItools is reall...

apitools.evconnect.com

EV Cloud Enterprise API

EV Connect Enterprise API.

apitools.it

API tools - Utensili e motori pneumatici industriali Atlas Copco

Benvenuto nella homepage di API sas div. Tools La nostra ambizione è quella di offrire le migliori soluzioni per l'aria compressa che ci consentano di essere la prima scelta per i nostri clienti. Da più di 30 anni siamo i Concessionari specializzati Tools Atlas Copco, conosciamo [.]. RAPID TORC - ATLAS COPCO CHIAVI DINAMOMETRICHE IDRAULICHE BASSO PROFILO. RAPID TORC - ATLAS COPCO. Torri di raffreddamento per acque industriali. Torrini estrattori aria, evacuatori fumo, cupole.

apitoon.com

Welcome to Apitoon Group - Surimi, Frozen Seafood and Surimi Based Products

APITOON GROUP, Thailand - Producer and exporter of frozen surimi, seafood, surimi-based products, fruit jelly, fish and shrimp feed, fish meal. Created and designed for APITOON GROUP. Fresh from the Sea to your Plate. Surimi, Surimi-Based Products, Frozen Seafood,. Fish and Shrimp Feed, Fish Meal.

apitop.com

La Pica de la Abeja, Miel de Abeja, Propoleo, Jalea Real, Apiturismo.

apitope.com

Apitope | Developing new therapies for the treatment of autoimmune and allergic diseases

Developing new therapies for the treatment of autoimmune and allergic diseases. Leadership & Senior Management Team. Auto-immune Diseases & Allergies. Elimination of Anti-drug Antibodies. Apitope is a European biotech company focused on the discovery and development of revolutionary disease modifying therapies for autoimmune and allergic diseases, including multiple sclerosis, Graves’ disease, FVIII intolerance and uveitis. Apitope Receives Orphan Designation in the European Union for ATX-F8-117 for the ...

apitopeka.org

API of Topeka

apitopo.com

The domain apitopo.com is for sale. To purchase, call Afternic.com at 1 781-373-6847 or 855-201-2286. Click here for more details.

apitorino.directio.it

Benvenuto API Torino - Directio

API Associazione Piccole e Medie Imprese di Torino e Provincia. Via Pianezza 123 - 10151 Torino - Centralino 011 4513111 - Fax 011 4513227 - apito@apito.it. Via Pianezza 123 - 10151 Torino - Tel. 011 4513297 - Fax 011 4551150 - segreteria@apiform.to.it.

apitorkeieioj.com

毎日の生活にインテリア

Posted in 未分類コメントは受け付けていません。

apitorosa.blogspot.com

Falando de Futebol...

Segunda-feira, 19 de dezembro de 2011. O tão esperado confronto! Tudo começou quando o Santos FC foi Campeão da Libertadores de 2011, foi ai que começaram a falar do tão esperado confronto, Santos FC x Barcelona. E muitos até mesmo diziam que seria o duelo onde se decidiria quem é o melhor jogador, Neymar ou Messi? Messi e companhia brilharam em campo. Quem é o melhor: Messi ou Neymar? BARCELONA CAMPEÃO MUNDIAL 2011. Compartilhar com o Pinterest. O tão esperado confronto! Visualizar meu perfil completo.